Zydus Wellness Limited

rs,

Code: 531 335 Code: ZYDUSWELL March 18, 2026 Listing Department BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchan

Rs. 10,000 million

tralite Mayonnaise 9 new products Launched Capital restructure (QIP and Preferential issue of Rs. 10,000 million) and repurchased NCDs of Rs. 15,000 million Launched new variant ‘Mango blast’ in Glucon-D A

Rs. 15,000 million

Capital restructure (QIP and Preferential issue of Rs. 10,000 million) and repurchased NCDs of Rs. 15,000 million Launched new variant ‘Mango blast’ in Glucon-D Acquisition of Naturell (India) Private Limit

₹126

position in several industry bodies. Business Overview Strong Infrastructure 1,600+ employees ₹126+ bn Market Cap 80,000 + shareholders 4 manufacturing facilities in India; Global 3P Manufact

rs 4

iness Overview Strong Infrastructure 1,600+ employees ₹126+ bn Market Cap 80,000 + shareholders 4 manufacturing facilities in India; Global 3P Manufacturers: 3 International & 15 Domestic Dedi

0.7 Million

e Business Overview Nourishes, Nurtures & Energizes over 70Mn families 1,950+ Distributors ~ 0.7 Million Direct Reach ~2.8 million stores 2,500+ feet on street representatives ~ 30,000 direct farme

2.8 million

shes, Nurtures & Energizes over 70Mn families 1,950+ Distributors ~ 0.7 Million Direct Reach ~2.8 million stores 2,500+ feet on street representatives ~ 30,000 direct farmers Source: Nielsen Report/

10%

uman and pet health segments Key Financial Metrics – FY 25 Revenue from Operations Healthy CAGR 10% 22,548 23,278 27,089 18,667 20,091 Personal Care Healthy CAGR 16.5% 33.4% 20.9% 17.0

16.5%

ations Healthy CAGR 10% 22,548 23,278 27,089 18,667 20,091 Personal Care Healthy CAGR 16.5% 33.4% 20.9% 17.0% -2.4% Food & Nutrition Consistent CAGR 8.3% 10.7% 0.4% 13.0% 9.4% FY21

33.4%

Healthy CAGR 10% 22,548 23,278 27,089 18,667 20,091 Personal Care Healthy CAGR 16.5% 33.4% 20.9% 17.0% -2.4% Food & Nutrition Consistent CAGR 8.3% 10.7% 0.4% 13.0% 9.4% FY21 FY22

20.9%

hy CAGR 10% 22,548 23,278 27,089 18,667 20,091 Personal Care Healthy CAGR 16.5% 33.4% 20.9% 17.0% -2.4% Food & Nutrition Consistent CAGR 8.3% 10.7% 0.4% 13.0% 9.4% FY21 FY22 FY23

17.0%

10% 22,548 23,278 27,089 18,667 20,091 Personal Care Healthy CAGR 16.5% 33.4% 20.9% 17.0% -2.4% Food & Nutrition Consistent CAGR 8.3% 10.7% 0.4% 13.0% 9.4% FY21 FY22 FY23 FY24 F

“FY24 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 Edible oils 29.3% vs.”

“✓ Comfort Click continues to deliver in line with expectations Geographic Mix for YTD FY26 Domestic International * * Including post acquisition Comfort Click business Q3 FY26 Q3 FY26 Growth Y-o-Y 134.0% Growth Y-o-Y -1.4% YTD FY26 YTD FY26 Growth Y-o-Y 48.9% Growth Y-o-Y -4.6% Gross Margin Performance Snapshot Most brands recorded gross margin expansion, underscoring the strength of the portfolio, with the uplift further supported by the newly acquired brands.”

“newly acquired Comfort Click business Organised Trade Saliency 13% FY21 Distributors 4.7% 17% 19% 21% 24% FY22 FY23 FY24 FY25 Total Reach * 8.8% 30% FY26* * YTD Dec’25 Feet-on-street Representatives 8.8% 1700 2.0 1950 2.8 2,000 2,800 FY 22 FY 25 FY 22 * in millions FY 25 FY 22 FY 25 Driving Brand Dominance and Market Relevance Category Category Size (in cr.) Mkt.”

“❖ Going forward, building on the strong brand equity, we plan to reframe Complan’s participation in the nutrition space with a set of relaunches and new product introductions to be more relevant for contemporary need states.”

“❖ Performance during YTD FY26 was impacted by seasonal headwinds affecting both the brand and the broader category.”

“❖ Delivered double-digit growth with a 6-year CAGR^ across the portfolio.”

“❖ Sugar Free, Complan, RiteBite - Max Protein and Nycil contributes a significant portion of the overall business Market Geography for YTD FY26 SAARC (excluding India) GCC African Countries Others * * Mainly includes New Zealand, Singapore, Mauritius, Morrocco, etc.”

Brands

1

Brands

WeightWorld, maxmedix, Animigo Key Milestones Note-1: Milestones that happened before Sugar Free and Everyuth hived off grom Zydus Lifesciences to Zydus Wellness Click for Corporate Video Board of Directors Dr. Sharvil P. Patel Non - Executive Chairman Dr. Sharvil Patel, Chairman and Non-Executive Director of our Company since April 2009, holds a bachelor's and doctorate in pharmaceutical science from the University of Sunderland, UK. With over two decades of experience in the pharmaceuticals industry, he serves as Managing Director of Zydus Lifesciences Limited. He has been conferred the ET Pharma leader of the year at the ET Healthworld India Pharma Awards 2022 and has been recognised as the Best CEO in the Lifesciences sector by Fortune India magazine Tarun Arora CEO & Whole Time Director Mr. Tarun Arora, CEO and Whole Time Director since May 2015, is a Harvard (AMP) and IMT Ghaziabad (PGDBM) alumnus. With 30 years of experience in strategy, innovation, and brand building, he has le